Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.2%

1 terminated/withdrawn out of 46 trials

Success Rate

96.2%

+9.7% vs industry average

Late-Stage Pipeline

24%

11 trials in Phase 3/4

Results Transparency

4%

1 of 25 completed trials have results

Key Signals

10 recruiting1 with results

Enrollment Performance

Analytics

N/A
19(50.0%)
Phase 4
7(18.4%)
Phase 2
5(13.2%)
Phase 3
4(10.5%)
Phase 1
3(7.9%)
38Total
N/A(19)
Phase 4(7)
Phase 2(5)
Phase 3(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (46)

Showing 20 of 46 trials
NCT07556887Not ApplicableNot Yet Recruiting

Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

Role: collaborator

NCT03884543Not ApplicableCompleted

Driving Pressure During General Anesthesia for Open Abdominal Surgery

Role: collaborator

NCT02998333Not ApplicableCompleted

Chronic Ankle Instability, Surgical Repair: Open Versus Closed

Role: collaborator

NCT06746246Not Yet Recruiting

Evaluation of Remote Monitoring of Liver Cirrhosis Patients

Role: collaborator

NCT06643286Not ApplicableRecruiting

Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

Role: collaborator

NCT01315015Not ApplicableCompleted

Breast Cancer Screening With MRI in Women Aged 50-75 Years With Extremely Dense Breast Tissue: the DENSE Trial

Role: collaborator

NCT06101511Not ApplicableRecruiting

Driving Pressure During General Anesthesia for Minimally Invasive Abdominal Surgery (GENERATOR)

Role: collaborator

NCT06766461Phase 4Recruiting

Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis

Role: collaborator

NCT06636370Not ApplicableRecruiting

Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial

Role: collaborator

NCT03564236Not ApplicableRecruiting

Nasal High-Flow in COPD

Role: collaborator

NCT06140199Not ApplicableNot Yet Recruiting

Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)

Role: collaborator

NCT03184194Phase 2Completed

Nivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide

Role: collaborator

NCT06350968Recruiting

Implementation of Online Advance Care Planning Tool for (Hemato-)Oncological Patients Within the Cancer Network Concord

Role: collaborator

NCT05266664Recruiting

Preterm Immune System Development and Response to Immunization

Role: collaborator

NCT05292651Not ApplicableRecruiting

Optimal Stent Deployment Strategy of Contemporary Stents

Role: lead

NCT05731687Not ApplicableRecruiting

Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy

Role: collaborator

NCT06130111Unknown

Spatial Location of Breast Cancer Local Recurrence After Mastectomy

Role: collaborator

NCT06010277Phase 4Unknown

Folinic Acid for Prevention of Pemetrexed-induced Toxicity

Role: collaborator

NCT02287480Phase 1Completed

VSV-ZEBOV Geneva Vaccine Trial

Role: collaborator

NCT05660226Not ApplicableRecruiting

Telemonitoring and E-Coaching in Hypertension

Role: collaborator